In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Myomo gets US nod for "smart" paralysis brace:

This article was originally published in Clinica

Executive Summary

The US FDA has approved a noninvasive, wearable, "smart" elbow brace that can help patients whose arms have become paralysed following a stroke relearn how to move their upper limbs. The Myomo e100 NeuroRobotic system, made by Boston, Massachusetts-based firm Myomo, enables patients to self-initiate and control movement of affected limbs using their own biological signals. No electrical stimulation or surgery is required. When a patient's electrical muscle activity signal fires in response to attempted movement, the device senses the signal from the skin's surface. It then employs advanced robotics to "reward" the patient with feedback in the form of actual motion. The theory is that by facilitating the patient's ability to practise tasks repeatedly, new connections are formed in the brain and existing connections are reinforced, resulting in improved ability to move the arm.

You may also be interested in...



COVID-19: WHO Supports Pooling Of Rights, MPP Includes Drugs and Tests

Intellectual property rights are in the spotlight again, after the World Health Organization and the Medicines Patent Pool announced initiatives to help ensure that all countries will be able to access products being developed for COVID-19.

'Hunker Down, Expect The Worst And Hope For The Best:' Investment Analyst Advises Medtech Businesses To Cut Costs

Maxim Jacobs, managing partner at Edison Investment Research urges medtech companies to be financially prudent as the COVID-19 pandemic worsens. Cancellations of routine surgeries are creating a huge strain on device businesses which could continue for months.

COVID-19: WHO Supports Pooling Of Rights, MPP Includes Drugs and Tests

Intellectual property rights are in the spotlight again, after the World Health Organization and the Medicines Patent Pool announced initiatives to help ensure that all countries will be able to access products being developed for COVID-19.

Topics

UsernamePublicRestriction

Register

MT049195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel